Učitavanje...
Phase 2 Trial of Paclitaxel Polyglumex with Capecitabine for Metastatic Breast Cancer
BACKGROUND: Capecitabine and paclitaxel are established effective treatments, alone and combined with other cytotoxic and targeted agents, for metastatic breast cancer (MBC). Paclitaxel polyglumex (a macromolecular conjugate of paclitaxel bound to poly-L-glutamic acid) has potential advantages over...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3593738/ https://ncbi.nlm.nih.gov/pubmed/23211220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0b013e31826e0550 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|